Zantrex-3 claims
This article was originally published in The Tan Sheet
Executive Summary
Electronic Retailing Self-Regulation Program will refer advertising for Basic Research's Zantrex-3 to the Federal Trade Commission because the firm "did not substantively address the core claims" cited in ERSRP's inquiry, the National Advertising Review Council group says Oct. 20. The request for substantiation was part of ERSRP's routine monitoring program. Zantrex-3 is an ephedra-free weight-loss supplement that claims to provide "546% more weight loss than the leading ephedrine-based diet pill," according to the product's 1website...